A Retrospective, Non-interventional, Multicenter, Observational Chart Review Study to Explore the Clinical Benefits of Retreatment With TKI in the Real World.
NCT01955681
·
clinicaltrials.gov ↗
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Locally Advanced or Metastatic EGFR Mutated NSCLC.
Sponsor
AstraZeneca